Kritische 8-K Meldungen
Stammdaten
Unternehmen
| Name | Aquestive Therapeutics, Inc. |
|---|---|
| Ticker | AQST |
| CIK | 0001398733 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Aquestive Therapeutics, Inc. |
Status
| Zuletzt geprüft | 2026-03-23 05:16:52.894135 |
|---|
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 44,545,000 | -83,784,000 | -0.78 | 160,425,000 | -33,662,000 |
| 2018-12-31 | 10-K | 67,430,000 |
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | Jung Cassie | Officer, Chief Operating Officer | Open Market Sale | -45,791 | 4.17 | -191,085.84 | -85,7% | |
| 2026-03-10 | Korczynski Sherry | Officer, Chief Commercial Officer | Open Market Sale | -15,741 | 4.17 | -65,687.19 | -29,5% | |
| 2026-03-10 | Barber Daniel | Officer, President and CEO | Open Market Sale | -180,677 | 4.17 | -753,965.12 | -338,2% | |
| 2026-03-10 | Boyd Peter E. | Officer, Chief People Officer | Open Market Sale | -29,814 | 4.17 | -124,413.82 | -55,8% | |
| 2026-03-10 | BRAENDER LORI J | Officer, Chief Legal Officer | Open Market Sale | -40,102 | 4.17 | -167,345.65 | -75,1% | |
| 2026-03-10 | Cioffi Melina | Officer, SVP, Regulatory Affairs | Open Market Sale | -25,311 | 4.17 | -105,622.80 | -47,4% | |
| 2026-03-10 | TOTH A ERNEST JR | Officer, Chief Financial Officer | Open Market Sale | -58,254 | 4.17 | -243,093.94 | -109,0% | |
| 2025-10-15 | Boyd Peter E. | Officer, See Remarks | Open Market Sale | -10,000 | 7.00 | -70,000.00 | -31,4% | |
| 2025-10-15 | Kraus Carl N | Officer, Chief Medical Officer | Open Market Sale | -20,272 | 7.00 | -141,904.00 | -63,7% | |
| 2025-10-15 | Jung Cassie | Officer, Chief Operating Officer | Open Market Sale | -67,575 | 7.01 | -473,700.75 | -212,5% | |
| 2025-09-26 | Boyd Peter E. | Officer, See Remarks | Open Market Sale | -10,000 | 6.30 | -63,000.00 | -28,3% | |
| 2025-09-26 | Barber Daniel | Director, Officer, President and CEO | Open Market Sale | -91,343 | 6.03 | -551,191.06 | -247,3% | |
| 2025-09-19 | Barber Daniel | Director, Officer, President and CEO | Open Market Sale | -400 | 6.00 | -2,400.00 | -1,1% | |
| 2025-09-05 | Boyd Peter E. | Officer, See Remarks | Open Market Sale | -15,000 | 5.30 | -79,500.00 | -35,7% | |
| 2025-09-04 | Jung Cassie | Officer, Chief Operating Officer | Open Market Sale | -62,180 | 5.00 | -310,900.00 | -139,5% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.